Stockreport

Heart Test stock rallies 27% on FDA update for MyoVista submission [Seeking Alpha]

HeartSciences Inc.  (HSCS) 
PDF the clearance pathway for its MyoVista wavECG device and associated AI-ECG algorithm from a De Novo submission to a more standard 510(k). Heart Test said the change sh [Read more]